These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2360589)

  • 1. The prevalence of substance abuse in patients with suspected preterm labor.
    Ney JA; Dooley SL; Keith LG; Chasnoff IJ; Socol ML
    Am J Obstet Gynecol; 1990 Jun; 162(6):1562-5; discussion 1565-7. PubMed ID: 2360589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine is associated with intrauterine fetal death in women with suspected preterm labor.
    Martinez A; Larrabee K; Monga M
    Am J Perinatol; 1996 Apr; 13(3):163-6. PubMed ID: 8688108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between recent cocaine use and pregnancy outcome.
    Spence MR; Williams R; DiGregorio GJ; Kirby-McDonnell A; Polansky M
    Obstet Gynecol; 1991 Sep; 78(3 Pt 1):326-9. PubMed ID: 1876358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preterm rupture of the membranes associated with recent cocaine use.
    Dinsmoor MJ; Irons SJ; Christmas JT
    Am J Obstet Gynecol; 1994 Aug; 171(2):305-8; discussion 308-9. PubMed ID: 8059806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripartum cocaine use: estimating risk of adverse pregnancy outcome.
    Cohen HR; Green JR; Crombleholme WR
    Int J Gynaecol Obstet; 1991 May; 35(1):51-4. PubMed ID: 1680076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine use during pregnancy: adverse perinatal outcome.
    MacGregor SN; Keith LG; Chasnoff IJ; Rosner MA; Chisum GM; Shaw P; Minogue JP
    Am J Obstet Gynecol; 1987 Sep; 157(3):686-90. PubMed ID: 3631169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors.
    Vaughn AJ; Carzoli RP; Sanchez-Ramos L; Murphy S; Khan N; Chiu T
    Obstet Gynecol; 1993 Jul; 82(1):92-6. PubMed ID: 8515933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants.
    Weathers WT; Crane MM; Sauvain KJ; Blackhurst DW
    Pediatrics; 1993 Feb; 91(2):350-4. PubMed ID: 8424009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal care and counseling of female drug-abusers: effects on drug abuse and perinatal outcome.
    Kukko H; Halmesmäki E
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):22-6. PubMed ID: 9926887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of cocaine abuse during pregnancy in Barcelona.
    Martinez Crespo JM; Antolín E; Comas C; Coll O; Marqués JM; Gual A; Fortuny A
    Eur J Obstet Gynecol Reprod Biol; 1994 Sep; 56(3):165-7. PubMed ID: 7821487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine abuse during pregnancy: maternal and fetal implications.
    Little BB; Snell LM; Klein VR; Gilstrap LC
    Obstet Gynecol; 1989 Feb; 73(2):157-60. PubMed ID: 2911419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between antepartum cocaine abuse, abnormal umbilical artery Doppler velocimetry, and placental abruption.
    Hoskins IA; Friedman DM; Frieden FJ; Ordorica SA; Young BK
    Obstet Gynecol; 1991 Aug; 78(2):279-82. PubMed ID: 2067775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard.
    Goler NC; Armstrong MA; Taillac CJ; Osejo VM
    J Perinatol; 2008 Sep; 28(9):597-603. PubMed ID: 18580882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening.
    Gillogley KM; Evans AT; Hansen RL; Samuels SJ; Batra KK
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1535-42. PubMed ID: 2240103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of use of cocaine and other substances in an obstetric population.
    Matera C; Warren WB; Moomjy M; Fink DJ; Fox HE
    Am J Obstet Gynecol; 1990 Sep; 163(3):797-801. PubMed ID: 2403158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical and clinical factors associated with positive urine toxicology screening on labor and delivery.
    Son SL; Guiahi M; Heyborne KD
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():261-266. PubMed ID: 30041147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse in pregnant women: recent experience at the Perinatal Center for Chemical Dependence of Northwestern Memorial Hospital.
    Keith LG; MacGregor S; Friedell S; Rosner M; Chasnoff IJ; Sciarra JJ
    Obstet Gynecol; 1989 May; 73(5 Pt 1):715-20. PubMed ID: 2704496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anonymous cocaine screening in a private obstetric population.
    Burke MS; Roth D
    Obstet Gynecol; 1993 Mar; 81(3):354-6. PubMed ID: 8437785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal outcome after recent cocaine usage.
    Mastrogiannis DS; Decavalas GO; Verma U; Tejani N
    Obstet Gynecol; 1990 Jul; 76(1):8-11. PubMed ID: 2359569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive surveillance for cocaine use in obstetric patients.
    Weeman JM; Zanetos MA; DeVoe SJ
    Am J Drug Alcohol Abuse; 1995 May; 21(2):233-9. PubMed ID: 7639209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.